Skip to main content

Testosterone

NDC 69097-363 · Cipla USA Inc.

Generic nameTestosterone
Dosage formSOLUTION
RouteTOPICAL
Active ingredient(s)TESTOSTERONE
Strength30 mg/1.5mL
Pharmacologic classAndrogen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
DEA scheduleCIII
Marketing categoryANDA

Packages

69097-363-44 — 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63629-9310 — testosterone, 64380-151 — Testosterone, 64380-152 — Testosterone, 66887-001 — testosterone, 66887-004 — testosterone, 66993-951 — testosterone, 66993-952 — testosterone, 66993-953 — testosterone, 66993-954 — testosterone, 66993-955 — testosterone, 68180-941 — Testosterone, 68180-943 — Testosterone, 69238-1013 — Testosterone, 70700-112 — Testosterone, 71335-2742 — testosterone, 72162-1274 — Testosterone Gel, 1%, 72162-1421 — testosterone, 72162-1426 — testosterone, 72162-1962 — Testosterone, 72603-265 — Testosterone, +32 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels